Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Screening for cervical cancer: should we test for infection with high-risk HPV?

× No keyword cloud information.

27 in total

1. Correspondence re: Sherman ME, Tabbara SO, Scott DR, Kurman RJ, Glass AG, Manos MM, et al. "Ascus, rule out HSIL": cytologic features, histologic correlates, and human papillomavirus detection. Mod Pathol 1999;12:335-42.

Authors: L G Koss
Journal: Mod Pathol Date: 2000-02 Impact factor: 7.842

Review 2. Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening.

Authors: C J Meijer; A J van den Brule; P J Snijders; T Helmerhorst; P Kenemans; J M Walboomers
Journal: IARC Sci Publ Date: 1992

3. Predicting mortality from cervical cancer after negative smear test results.

Authors: G J van Oortmarssen; J D Habbema; M van Ballegooijen
Journal: BMJ Date: 1992-08-22

4. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group.

Authors:
Journal: J Natl Cancer Inst Date: 2000-03-01 Impact factor: 13.506

5. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors: J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal: J Pathol Date: 1999-09 Impact factor: 7.996

6. Screening for cervical neoplasia by self-assessment for human papillomavirus DNA.

Authors: P Hillemanns; R Kimmig; U Hüttemann; C Dannecker; C J Thaler
Journal: Lancet Date: 1999-12-04 Impact factor: 79.321

7. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.

Authors: J W Sellors; A T Lorincz; J B Mahony; I Mielzynska; A Lytwyn; P Roth; M Howard; S Chong; D Daya; W Chapman; M Chernesky
Journal: CMAJ Date: 2000-09-05 Impact factor: 8.262

8. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group.

Authors: J W Sellors; J B Mahony; J Kaczorowski; A Lytwyn; H Bangura; S Chong; A Lorincz; D M Dalby; V Janjusevic; J L Keller
Journal: CMAJ Date: 2000-09-05 Impact factor: 8.262

9. Genital papillomavirus infection after treatment for cervical intraepithelial neoplasia (CIN) III.

Authors: P Bistoletti; A Zellbi; J Moreno-Lopez; A Hjerpe
Journal: Cancer Date: 1988-11-01 Impact factor: 6.860

10. Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia.

Authors: O Lungu; X W Sun; J Felix; R M Richart; S Silverstein; T C Wright
Journal: JAMA Date: 1992-05-13 Impact factor: 56.272

11 in total

1. Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.

Authors: Maria T Sandri; Paola Lentati; Elvira Benini; Patrizia Dell'Orto; Laura Zorzino; Francesca M Carozzi; Patrick Maisonneuve; Rita Passerini; Michela Salvatici; Chiara Casadio; Sara Boveri; Mario Sideri
Journal: J Clin Microbiol Date: 2006-06 Impact factor: 5.948

2. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test.

Authors: Dennis van Hamont; Maaike A P C van Ham; Judith M J E Bakkers; Leon F A G Massuger; Willem J G Melchers
Journal: J Clin Microbiol Date: 2006-09 Impact factor: 5.948

3. A Mathematical Model of Cell Cycle Dysregulation Due to Human Papillomavirus Infection.

Authors: Anna K Miller; Karl Munger; Frederick R Adler
Journal: Bull Math Biol Date: 2017-06-12 Impact factor: 1.758

4. Human Papillomavirus Vaccine Impact on Cervical Precancers in a Low-Vaccination Population.

Authors: Jaimie Z Shing; Marie R Griffin; Rachel S Chang; Alicia Beeghly-Fadiel; Staci L Sudenga; James C Slaughter; Manideepthi Pemmaraju; Edward F Mitchel; Pamela C Hull
Journal: Am J Prev Med Date: 2021-10-29 Impact factor: 5.043

5. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study.

Authors: Susanne K Kjaer; Adriaan J C van den Brule; Gerson Paull; Edith I Svare; Mark E Sherman; Birthe L Thomsen; Mette Suntum; Johannes E Bock; Paul A Poll; Chris J L M Meijer
Journal: BMJ Date: 2002-09-14

6. Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene.

Authors: Sean F Jabbar; Linda Abrams; Adam Glick; Paul F Lambert
Journal: Cancer Res Date: 2009-05-12 Impact factor: 12.701

7. Human papillomavirus infection in Honduran women with normal cytology.

Authors: N Tábora; J M J E Bakkers; W G V Quint; L F A G Massuger; J A Matute; W J G Melchers; A Ferrera
Journal: Cancer Causes Control Date: 2009-08-15 Impact factor: 2.506

8. A large cross-sectional survey investigating the knowledge of cervical cancer risk aetiology and the predictors of the adherence to cervical cancer screening related to mass media campaign.

Authors: Corrado De Vito; Claudio Angeloni; Emma De Feo; Carolina Marzuillo; Amedeo Lattanzi; Walter Ricciardi; Paolo Villari; Stefania Boccia
Journal: Biomed Res Int Date: 2014-06-12 Impact factor: 3.411

9. Evaluation of 3D-CPA, HR-HPV, and TCT joint detection on cervical disease screening.

Authors: Hui Liang; Min Fu; Jian Zhou; Lei Song
Journal: Oncol Lett Date: 2016-06-02 Impact factor: 2.967

10. Association between folate status and cervical intraepithelial neoplasia.

Authors: W Zhao; M Hao; Y Wang; N Feng; Z Wang; W Wang; J Wang; L Ding
Journal: Eur J Clin Nutr Date: 2016-03-30 Impact factor: 4.016